Sort
30,917 grants matching “tumor microenvironment”
Multidimensional analyses to improve PSMA-RPT efficacy in mCRPC
$584,235Johannes Czernin · University Of California Los Angeles · R01 · FY2025 · CA
Engineering immunotherapeutic probiotics to mitigate irAE
$584,146Tal Danino · Columbia Univ New York Morningside · U01 · FY2022 · CA
Patient-specific, high-sensitivity spectral CT for assessment of pancreatic cancer
$583,894Peter B Noãl · University Of Pennsylvania · R01 · FY2024 · EB
Intratumor co-delivery of DNA and RNA to relieve cancer pain
$583,847Brian L Schmidt · New York University · R01 · FY2025 · DE
Intratumor co-delivery of DNA and RNA to relieve cancer pain
$583,847Brian L Schmidt · New York University · R01 · FY2021 · DE
Intratumor co-delivery of DNA and RNA to relieve cancer pain
$583,847Brian L Schmidt · New York University · R01 · FY2023 · DE
Project 1: Multi-scale modeling of adaptive drug resistance in BRAF-mutant melanoma
$583,801Peter Karl Sorger · Harvard Medical School · U54 · FY2018 · CA
Temporal analysis of the GBM tumor microenvironment during myeloid cell activating therapy
$583,794Ralph Weissleder · Massachusetts General Hospital · R01 · FY2025 · CA
Glycosylation and Immune Evasion in Urologic Tumors
$583,786Sharon Pitteri · Stanford University · U01 · FY2023 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$583,776William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Dissecting the role of hypoxia in T cell differentiation in cancer
$583,740Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Therapeutic Targeting Mitochondrial C1 Metabolism
$583,716Larry H. Matherly · Wayne State University · R01 · FY2024 · CA
Tech Core 2
$583,706Denis Wirtz · Johns Hopkins University · U54 · FY2022 · CA
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
$583,657T.-C. Wu · Johns Hopkins University · R01 · FY2020 · CA
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
$583,532Brian Till · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Focused ultrasound pre-conditioning for augmented nanoparticle penetration in infiltrative gliomas
$583,441Richard J Price · University Of Virginia · R01 · FY2023 · EB
Exploring DNA damage response pathways as targets for cancer therapy
$583,430Junjie Chen · University Of Tx Md Anderson Can Ctr · R35 · FY2022 · CA
Metformin for chemoprevention of lung cancer in obese subjects at high risk
$583,338Saikrishna Yendamuri · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
$583,258T.-C. Wu · Johns Hopkins University · R01 · FY2021 · CA
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy
$583,254John Kurhanewicz · University Of California, San Francisco · R01 · FY2014 · CA
Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology.
$583,253Nicole Franziska Steinmetz · University Of California, San Diego · U01 · FY2021 · CA
The Role of Kaiso as a predictive breast cancer biomarker in Africa and across the African Diaspora
$583,243Kevin L. Gardner · Columbia University Health Sciences · R01 · FY2025 · CA
Protein kinase C signaling in prostate cancer health disparities
$583,194Marcelo Gabriel Kazanietz · University Of Miami School Of Medicine · R01 · FY2025 · CA
Validation of a novel 3D culture platform for TNBC treatment selection
$583,104Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2024 · CA
Immune Therapy for Brain Metastasis
$583,091Lucia Beatrice Jilaveanu · Yale University · R01 · FY2023 · CA